New 2α-tropane amides as potential PET ligands for the dopamine transporter

Nuclear Medicine and Biology

Volumn 34, Issue 5, 2007, Pages 531-539

  Drewes, Birte ^a   Sihver, Wiebke ^a   Willbold, Sabine ^a   Olsson, Ray A ^a   Coenen, Heinz H ^a  

^a FORSCHUNGSZENTRUM JÜLICH   (Germany)

Author keywords

2 ,3 Tropanes; Cocaine derivatives; DAT ligands; PET

Indexed keywords

2BETA CARBOMETHOXY 3BETA (4 IODOPHENYL)TROPANE I 131; 3BETA (4 IODOPHENYL) 8 METHYL 8 AZABICYCLO[3.2.1]OCTANE 2ALPHA CARBOXYLIC ACID (2 FLUOROETHYL)AMIDE; 3BETA (4 IODOPHENYL) 8 METHYL 8 AZABICYCLO[3.2.1]OCTANE 2BETA CARBOXYLIC ACID (2 FLUOROETHYL)AMIDE; 3BETA (4 TOLYL) 8 METHYL 8 AZABICYCLO[3.2.1]OCTANE 2ALPHA CARBOXYLIC ACID (2 FLUOROETHYL)AMIDE; 8 (3 IODOPROP 2 ENYL) 3BETA 4 TOLYL 8 AZABICYCLO[3.2.1]OCTANE 2ALPHA CARBOXYLIC ACID (2 FLUOROETHYL)AMIDE; 8 (3 IODOPROP 2 ENYL) 3BETA 4 TOLYL 8 AZABICYCLO[3.2.1]OCTANE 2ALPHA CARBOXYLIC ACID 2 FLUOROETHYL ESTER; DOPAMINE TRANSPORTER; RADIOPHARMACEUTICAL AGENT; TROPANE DERIVATIVE; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; LIGAND;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; BRAIN CORTEX; BRAIN HOMOGENATE; COMPETITIVE INHIBITION; CONTROLLED STUDY; CORPUS STRIATUM; MOLECULAR IMAGING; NEUROIMAGING; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RAT; SPECIES COMPARISON; STRUCTURE ACTIVITY RELATION; SWINE; WISTAR RAT; ANIMAL; COMPARATIVE STUDY; FEASIBILITY STUDY; IN VITRO STUDY; METABOLIC CLEARANCE RATE; METABOLISM; METHODOLOGY; SCINTISCANNING; SYNTHESIS; TISSUE DISTRIBUTION;

ANIMALS; CORPUS STRIATUM; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEASIBILITY STUDIES; LIGANDS; METABOLIC CLEARANCE RATE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RATS; RATS, WISTAR; SWINE; TISSUE DISTRIBUTION; TROPANES;

EID: 34250710744     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2007.04.007     Document Type: Article

References (56)

1. Schenk J.O. The functioning neuronal transporter for dopamine: kinetic mechanisms and effects of amphetamines, cocaine and methylphenidate. Prog Drug Res 59 (2002) 113-131
2. Torres G.E., Carneiro A., Seamans K., Fiorentini C., Sweeney A., Yao W.D., et al. Oligomerization and trafficking of the human dopamine transporter. J Biol Chem 278 (2003) 2731-2739
3. Giros B., Jaber M., Jones S.R., Wightman R.M., and Caron M.G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379 (1996) 606-612
4. Horn A. Characteristics of transport in dopaminergic neurons. In: Paton D.M. (Ed). The mechanism of neuronal and extraneuronal transport of catecholamines (1976), Raven Press, New York 195-214
5. Clarke R.L., Daum S.J., Gambino A.J., Aceto M.D., Pearl J., Levitt M., et al. Compounds affecting the central nervous system. 4.3β-Phenyltropane-2-carboxylic esters and analogs. J Med Chem 16 (1973) 1260-1267
6. 3H]cocaine binding to the dopamine transporter in Parkinson's disease. Eur J Pharmacol 95 (1983) 145-146
7. Kuhar M.J., Ritz M.C., and Boja J.W. The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci 14 (1991) 299-302
8. Innis R.B., Seibyl P., Scanley B.E., Laruell M., Abi-Dargham A., and Wallace E. Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters on parkinson disease. Proc Natl Acad Sci U S A 90 (1993) 11965-11969
9. 123I]β-CIT striatal uptake correlates with symptom severity in Parkinson's disease. Ann Neurol 8 (1995) 589-598
10. Singh S. Chemistry, design, and structure-activity relationship of cocaine antagonists. Chem Rev 100 (2000) 925-1024
11. Carroll F.I., Gao Y., Rahman M.A., Abraham P., Parham K., Lewin A.H., et al. Synthesis, ligand binding, QSAR, and CoMFA study of 3β-(p-substituted phenyl)tropane-2β-carboxylic acid methyl esters. J Med Chem 34 (1991) 2719-2725
12. 18F]-N-3-fluorpropyl-2β-carbomethoxy-3-β-(4-iodophenyl) nortropane and the first human study with positron emission tomography. Nucl Med Biol 23 (1996) 999-1004
13. Emond P., Garreau L., Chalon S., Boazi M., Caillet M., Bricard J., et al. Synthesis and ligand binding of nortropane derivatives: N-substituted 2β-carbomethoxy-3β-(4′-iodophenyl)nortropane and N-(3-Iodoprop-(2E)-enyl)-2β-carbomethoxy-3β-(3′, 4′-disubstituted phenyl)nortropane. New high-affinity and selective compounds for the dopamine transporter. J Med Chem 40 (1997) 1366-1372
14. 18F]Fluoroethylbromid. Appl Radiat Isot 46 (1995) 765-770
15. 18F-Labeled FECNT: a selective radioligand for PET imaging of brain dopamine transporters. Nucl Med Biol 27 (2000) 1-12
16. Dolle F., Emond P., Mavel S., Demphel S., Hinnen F., Mincheva Z., et al. Synthesis, radiosynthesis and in vivo preliminary evaluation of [C-11]LBT-999, a selective radioligand for the visualisation of the dopamine transporter with PET. Bioorg Med Chem 14 (2006) 1115-1125
17. 18F]fluorobut-2-en-1-yl)-2β-carbomethoxy-3β-((4-substituted-phenyl)nortropanes for imaging DAT by PET. J Labelled Cmpd Radiopharm 42 (1999) S400-S402
18. Goodman MM, Chen P. Fluoroalkenyl nortropanes. WO 00064490 A1: U.S. Patent 2000;37.
19. Kotian P., Mascarella W.S., Abraham P., Lewin A.H., Boja J.W., Kuhar M.J., et al. Synthesis, ligand binding, and quantitative structure-activity relationship study of 3β-(4′-substituted phenyl)-2β-heterocyclic tropanes: evidence for an electrostatic interaction at the 2β-position. J Med Chem 39 (1996) 2753-2763
20. 11C]-β-CPPIT, a cocaine derivative lacking the 2β-ester function. Nucl Med Biol 29 (2002) 19-27
21. Thiruvazhi M., Abraham P., Kuhar M.J., and Carroll F.I. Synthesis of the isomers of (1R)-3-(phenylthio)tropane-2-carboxylic acid methyl ester. A new class of ligands for the dopamine transporter. Chem Commun 21 (1997) 555-556
22. Zhao L.Y., and Kozikowski A.P. Synthesis of the 2 beta,3 beta-, 2 alpha,3 beta-, 2 beta,3 alpha- and 2 alpha,3 alpha- isomers of 6 beta-hydroxy-3-(p-tolyl)tropane-2-carboxylic acid methyl ester. Tetrahedron Lett 40 (1999) 4961-4964
23. Carroll F.I., Runyon S.P., Abraham P., Navarro H., Kuhar M.J., Pollard G.T., et al. Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers. J Med Chem 47 (2004) 6401-6409
24. Lomenzo S.A., Izenwasser S., Katz J.L., Terry P.D., Zhu N., Klein C.L., et al. Synthesis, structure, dopamine transporter affinity, and dopamine uptake inhibition of 6-alkyl-3-benzyl-2-[(methoxycarbonyl)methyl]tropane derivatives. J Med Chem 40 (1997) 4406-4414
25. Carroll F.I., Abraham P., Kuzemko M.A., Gray J.L., and Lewin A.H. Synthesis and cocaine receptor affinities of 3-phenyl-2-(3′-methyl-1,2,4-oxadiazole-5′-yl)tropane isomers. J Chem Soc Chem Commun 1 (1993) 44-46
26. Carroll F.I., Gray L.J., Abraham P., Kuzemko M.A., Lewin A.H., Boja J.W., et al. 3-Aryl-2-(3′-substituted-1′,2′,4′-oxadiazol-5′-yl)tropane analogs of cocaine: affinities at the cocaine binding site at the dopamine, serotonin, and norepinephrine transporters. J Med Chem 36 (1993) 2886-2890
27. Carroll F.I., Lewin A.H., Abraham P., Parham K., Boja J.W., and Kuhar M.J. Synthesis and ligand binding of cocaine isomers at the cocaine receptor. J Med Chem 34 (1991) 883-886
28. 131I]β-CIT. Nucl Med Biol 34 (2007) 211-219
29. Neumeyer J.L., Wang S., Yigong G., Milius R.A., Kula N.S., Campbell A., et al. N-ω-Fuoroalkyl analogs of (1R)-2β-carbomethoxy-3β-(4-iodophenyl)-tropane (β-CIT): radiotracers for positron emission tomography and single photon emission computed tomography imaging of dopamine transporters. J Med Chem 37 (1994) 1558-1561
30. Meltzer P.C., Liang A.L., Brownell A.Ö., Elmaleh D.R., and Madras B.K. Substituted 3-phenyltropane analogs of cocaine: synthesis, inhibition of binding at cocaine recognition sites, and positron emission tomography imaging. J Med Chem 36 (1993) 855-862
31. Xu L., and Trudell M.L. Stereoselective synthesis of 2β-carbomethoxy-3β-phenyltropane derivates. Enhanced stereoselectivity observed for the conjugate addition reaction of phenylmagnesiumbromid derivatives with anhydro dichloromethane. J Heterocycl Chem 33 (1996) 2037-2039
32. Milius R.A., Saha J.K., Madras B.K., and Neumeyer J.L. Synthesis and receptor binding of N-substituted tropane derivatives. High-affinity ligands for the cocaine receptor. J Med Chem 34 (1991) 1728-1731
33. Swahn C.G., Halldin C., Gunther I., Günther I., Patt J., and Ametamey S. Synthesis of unlabelled, H-3- and I-125-labelled beta-CIT and its omega-fluoroalkyl analogues beta-CIT-FE and beta-CIT-FP, including synthesis of precursors. J Labelled Compd Radiopharn 38 (1996) 675-685
34. Carroll F.I., Gao Y.G., Abraham P., Lewin A.H., Lew R., Patel A., et al. Probes for the cocaine receptor. Potentially irreversible ligands for the dopamine transporter. J Med Chem 35 (1992) 1813-1817
35. Shioiri T., Yokoyama Y., Kasai Y., and Yamada S. Phosphorous in organic synthesis. Tetrahedron 32 (1976) 2211-2217
36. Edgell W.F., and Parts L. Synthesis of alkyl and substituted alkyl fluorides from p-toluenesulfonic acid esters. The preparation of p-toluenesulfonic acid esters of lower alcohols. J Am Chem Soc 77 (1955) 4899-4902
37. 18F]fluoroethylbromid. Appl Radiat Isot 46 (1995) 765-770
38. Carroll F.I., Kotian P., Dehghani A., Gray J.L., Kuzemko M.A., Parham K.A., et al. Cocaine and 3β-(4′-substituted phenyl)tropane-2β-carbocylic acid ester and amide analogues. New high-affinity and selective compounds for the dopamine transporter. J Med Chem 38 (1995) 379-388
39. Krebs B., and Flörke U. N-(2-Fluoroethyl)-3 beta-(4-iodophenyl)-8-methyl-8-azabicyclo[3.2.1]octane-2 alpha-carboxamide: a new cocaine derivative with equatorially attached ligands. Acta Cryst C60 (2004) o118-o119
40. Xu L., and Trudell M.L. Stereoselective synthesis of 2β-carbomethoxy-3β-phenyltropane derivates. Enhanced stereoselectivity observed for the conjugate addition reaction of phenylmagnesiumbromid derivatives with anhydro dichloromethane. J Heterocycl Chem 33 (1996) 2037-2039
41. Gee A.D., Moldt P., and Gjedde A. The labelling of a novel tropane derivative [C-11]NS 2214 (BMS-204756) - an inhibitor of the dopamine transporter. J Labelled Compd Radiopharm 39 (1997) 959-972
42. Lidov H.G., Grzanna R., and Molliver M.E. Serotonin innervation of the cerebral-cortex in the rat - immunohistochemical analysis. Neuroscience 5 (1980) 207-227
43. Boja J.W., Cline E.J., Carroll F.I., Lewin A.H., Philip A., Dannals R., et al. High potency cocaine analogs - neurochemical, imaging and behavioural-studies. Ann N Y Acad Sci 654 (1992) 282-291
44. Monteiro-Riviere N.A., and Tumbleson M.E. In: Tumbleson M.E. (Ed). Swine in biomedical research vol 1 (1986), Plenum, New York 437-440
45. Dickerson J.W.T. Dobbing. Effect of undernutrition on postnatal development of brain and cord in pigs. J Proc R Soc Lond Ser B Biol Sci 166 (1967) 384
46. Munkeby B.H., Lyng K., Froen J.F., Winther-Larssen E.H., Rosland J.H., Smith H.J., et al. Morphological and hemodynamic magnetic resonance assessment of early neonatal brain injury in a piglet model. J Magn Reson Imaging 20 (2004) 8-15
47. Miller G.M., Yatin S.M., De La Garza II R., Goulet M., and Madras B.K. Cloning of dopamine, norepinephrine and serotonin transporters from monkey brain: relevance to cocaine sensitivity. Brain Res Mol Brain Res 87 (2001) 124-143
48. Peng X., Zhang A., Kula N.S., Baldessarini R.J., and Neumeyer J.L. Synthesis and transporter affinities of novel phenyltropane derivatives as potential positron emission tomography (PET) imaging agents. Bioorg Med Chem 14 (2004) 5635-5639
49. Krebs B., Bier D., Sihver W., Holschbach M., and Coenen H.H. New promising radiofluorinated dopamine transporter ligands: synthesis, n.c.a radiofluorination and preliminary evaluation. J Labelled Compd Radiopharm 46 (2003) S53
50. Chalon S., Garreau L., Emond P., Zimmer L., Vilar M.P., Besnard J.C., et al. Pharmacological characterisation of (E)-N-(3-iodoprop-2-enyl)-2β-carbomethoxy-3β-(4′-methylphenyl)nortropane as a selective and potent inhibitor of the neuronal dopamine transporter. Pharmacol Exp Ther 291 (1999) 648-654
51. Halldin C., Erixon-Lindroth N., Pauli S., Chou Y.H., Okubo Y., Karlsson P., et al. [C-11]PE2I: a highly selective radioligand for PET examination of the dopamine transporter in monkey and human brain. Eur J Nucl Med Mol Imaging 30 (2003) 1220-1230
52. Guilloteau D., Emond P., Baulieu J.L., Garreau L., Frangin Y., Pourcelot L., et al. Exploration of the dopamine transporter: in vitro and in vivo characterization of a high-affinity and high-specificity iodinated tropane derivative (E)-N-(3-iodoprop-2-enyl)-2β-carbomethoxy-3β-(4′-methylphenyl)nortropane (PE2I). Nucl Med Biol 25 (1998) 331-337
53. Dall A.M., Danielsen E.H., Sorensen J.C., Andersen F., Moller A., Zimmer J., et al. Quantitative [F-18]fluorodopa/PET and histology of fetal mesencephalic dopaminergic grafts to the striatum of MPTP-poisoned minipigs. Cell Transplant 11 (2002) 733-746
54. Minuzzi L., Olsen A.K., Bender D., Arnfred S., Grant R., Danielsen E.H., et al. Quantitative autoradiography of ligands for dopamine receptors and transporters in brain of Gottingen minipig: comparison with results in vivo. Synapse 59 (2006) 211-219
55. Lehtinen S. Neurotoxicity in children after treatment for acute lymphoblastic leukaemia and methotrexate neurotoxicity in a controlled animal model. Acta Univ Ouluensis, D Med 728 (2003) ISBN: 951-42-7032-0; ISSN: 0355-3221
56. Lewin A.H., Gao Y.G., Abraham P., Boja J.W., Kuhar M.J., and Carroll F.I. 2.beta.-Substituted analogs of cocaine. Synthesis and inhibition of binding to the cocaine receptor. J Med Chem 35 (1992) 135-140